Neurodevelopmental outcome of extremely low birth weight infants with Candida infection

Ira Adams-Chapman1, Carla M Bann, Abhik Das

  • 1Department of Pediatrics, Emory University, Atlanta, GA.

Insights

Candida infections in extremely low birth weight (ELBW) infants increase the risk of death and neurodevelopmental impairment (NDI). This risk is highest for infants with Candida sepsis or meningitis.

Area of Science:

  • Neonatal Research
  • Infectious Diseases
  • Pediatric Neurology

Background:

  • Candida infections pose a significant threat to preterm infants, particularly those with extremely low birth weight (ELBW).
  • Late-onset sepsis in ELBW infants is associated with adverse outcomes, including mortality and neurodevelopmental impairment (NDI).

Purpose of the Study:

  • To evaluate the mortality and neurodevelopmental outcomes of ELBW infants based on their infection status in the Candida study.
  • To compare outcomes between infected and uninfected ELBW infants and with a control group not screened for sepsis.

Main Methods:

  • Retrospective analysis of ELBW infants (born 2004-2007) enrolled in the Neonatal Research Network (NRN) Candida study.
  • Neurodevelopmental impairment assessed at 18 months using Bayley Scales of Infant Development-II or -III.
  • Comparison with a control group from the NRN Generic Database not screened for sepsis.

Main Results:

  • Among ELBW infants in the Candida study, 31% with Candida sepsis and 31% with non-Candida sepsis experienced NDI.
  • Candida sepsis or meningitis increased the risk of death and the composite outcome of death and/or NDI.
  • Candida infection was associated with a higher likelihood of NDI compared to infants never screened for sepsis (OR 1.83).

Conclusions:

  • ELBW infants with any sepsis or meningitis face elevated risks of death and NDI.
  • Candida sepsis and/or meningitis present the highest risk for adverse outcomes in this vulnerable population.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...